Recent Expansions Neuraxpharm has expanded its operations into the Middle East, Germany, and Brazil, presenting significant sales opportunities in these new markets for their CNS products.

New Product Launches The recent launch of multiple sclerosis treatment in Europe and BRIUMVI in Germany indicates a focus on introducing innovative products, creating avenues for increased sales and market penetration.

Strategic Partnerships Partnerships with companies like TG Therapeutics, Inc. for commercialization agreements open doors for leveraging each other's strengths and networks, potentially leading to expanded sales channels.

Acquisitions Strategy Through acquisitions like Libberpharma in Brazil and Lazap for atypical antipsychotic drugs, Neuraxpharm is strategically expanding its portfolio, providing access to new customer segments and revenue streams.

Global Distribution Network With a direct presence in over 20 European countries and partners in more than 40 countries globally, Neuraxpharm has a strong distribution network that can be leveraged to increase sales and market reach.